Archived Newsletters
-
02.27.24 -- Take Your Small Molecule Drug Development To The Next Level
2/27/2024
02/27/24 Outsourced Pharma Newsletter
-
02.27.24 -- Novo Holdings Clarifies, But Competitors Circling Catalent
2/27/2024
02/27/24 Outsourced Pharma Newsletter
-
02.26.24 -- Enhancing Drug Development Outcomes Through Early Assessment Strategies
2/26/2024
02/26/24 Outsourced Pharma Newsletter
-
02.26.24 -- Novel Approaches For Obtaining High-productivity Clones
2/26/2024
02/26/24 Outsourced Pharma Newsletter
-
02.23.24 -- Services, Technologies, And Innovations In Fill/Finish
2/23/2024
02/23/24 Outsourced Pharma Newsletter
-
02.23.24 -- Getting Generic Drugs Right: FDA Revises ANDA Guidance
2/23/2024
02/23/24 Outsourced Pharma Newsletter
-
02.22.24 -- Discover Partners Focused On Cell & Gene Therapy
2/22/2024
02/22/24 Outsourced Pharma Newsletter
-
02.22.24 -- Develop A Robust Modified Release OSD Formulation Strategy
2/22/2024
02/22/24 Outsourced Pharma Newsletter
-
02.22.24 -- What A Process Chemist Learned At CDMOs
2/22/2024
02/22/24 Outsourced Pharma Newsletter
-
02.21.24 -- Nanoparticle Enabled Formulation And Drug Delivery Solutions
2/21/2024
02/21/24 Outsourced Pharma Newsletter
This website uses cookies to ensure you get the best experience on our website. Learn more